Gastric Mucosal Changes in Patients With Dermatomyositis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05402670

Enrollment

150

Registered

2022-06-02

Start date

2022-06-01

Completion date

2023-06-01

Last updated

2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Mucosal Manifestations in Patients With Dermatomyositis

Brief summary

There are a large number of reports in the literature that patients with dermatomyositis often have various malignant tumors, and reports of gastric cancer are not rare. At present, the widely recognized gastric cancer occurrence patterns are: normal gastric mucosa-chronic superficial gastritis-chronic atrophic gastritis-intestinal metaplasia-dysplasia-gastric cancer, so the research about the gastric mucosal performance of patients with dermatomyositis is clinically meaningful

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* 1、18-70years old，no gender limit. 2、Clinical diagnosis of dermatomyositis. 3、dermatomyositis group conform to 1 and 2，control group conform to 1 .

Exclusion criteria

* Contraindications for gastroscopy. * Past history of malignant tumors of the esophagus and stomach and or history of surgery. * Pregnant or lactating women. ④ Participated in other clinical studies within 3 months. ⑤Patients cannot express their main complaints correctly and cannot cooperate with the research.

Design outcomes

Primary

Measure	Time frame	Description
Gastric mucosal manifestations	1 year	Normal gastric mucosa、chronic superficial gastritis、chronic atrophic gastritis、intestinal metaplasia、dysplasia、gastric cancer、gastric ulcer and so on

Countries

China

Outcome results